BioLife Solutions, Inc. Shares Issued, Shares, Share-based Payment Arrangement, Forfeited
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BioLife Solutions, Inc. shares issued, shares, share-based payment arrangement, forfeited for the quarter ending 2018-03-31 was 730.00 shares.
- BioLife Solutions, Inc. shares issued, shares, share-based payment arrangement, forfeited for the quarter ending 2014-06-30 was -2.16K shares.
- BioLife Solutions, Inc. shares issued, shares, share-based payment arrangement, forfeited for the quarter ending 2014-03-31 was -46.84K shares.
- BioLife Solutions, Inc. shares issued, shares, share-based payment arrangement, forfeited for the quarter ending 2013-12-31 was 351.00K shares, a 19.61% decline year-over-year.
- BioLife Solutions, Inc. shares issued, shares, share-based payment arrangement, forfeited for fiscal 2013 was -29.00K shares.
- BioLife Solutions, Inc. shares issued, shares, share-based payment arrangement, forfeited for fiscal 2012 was -38.38K shares.
| Period end | Shares Issued, Shares, Share-based Payment Arrangement, Forfeited 3 month | Shares Issued, Shares, Share-based Payment Arrangement, Forfeited 12 month |
|---|---|---|
| 2018-03-31 | 730.00 shares 10-Q · filed 2018-05-11 | |
| 2014-06-30 | -2.16K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | 122.00K shares derived: sum of 4 quarters · filed 2014-08-07 |
| 2014-03-31 | -46.84K shares 10-Q · filed 2014-05-08 | 74.16K shares derived: sum of 4 quarters · filed 2014-05-08 |
| 2013-12-31 | 351.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-12 | -29.00K shares 10-K · filed 2014-02-12 |
| 2013-09-30 | -180.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | 56.62K shares derived: sum of 4 quarters · filed 2014-02-12 |
| 2013-06-30 | -50.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | 86.62K shares derived: sum of 4 quarters · filed 2014-02-12 |
| 2013-03-31 | -150.00K shares 10-Q · filed 2013-05-14 | |
| 2012-12-31 | 436.62K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-12 | -38.38K shares 10-K · filed 2014-02-12 |
| 2012-09-30 | -150.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |